ASCO22 - Highlights prostaat- en blaascarcinoom

Koos van der Hoeven bespreekt met Debbie Robbrecht ontwikkelingen bij blaas- en prostaatcarcinoom. Aan bod komen onder andere de rol van (neo-adjuvante) immunotherapie bij niet-spierinvasief blaascarcinoom, de rol van ctDNA bij spierinvasief blaascarcinoom, cabozanitinib bij gemetastaseerd blaascarcinoom en de TheraP-studie en ENZAMET-studie bij het prostaatcarcinoom.

Episode metadata supplied by the publisher feed · Published Jun 9, 2022

Embed this episode

Attribution link and audio player

Ready to play

ASCO22 - Highlights prostaat- en blaascarcinoom

0:00 29:21

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Oncologie.nu?

This episode is 29 minutes long.

When was this Oncologie.nu episode published?

This episode was published on June 9, 2022.

Can I download this Oncologie.nu episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!